NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 20 filers reported holding NABRIVA THERAPEUTICS PLC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $108,000 | +28.6% | 200,992 | +61.2% | 0.00% | – |
| Q2 2020 | $84,000 | +31.2% | 124,679 | +12.8% | 0.00% | – |
| Q1 2020 | $64,000 | -43.9% | 110,493 | +28.4% | 0.00% | – |
| Q4 2019 | $114,000 | -36.3% | 86,067 | -4.2% | 0.00% | – |
| Q3 2019 | $179,000 | +5.9% | 89,833 | +28.8% | 0.00% | – |
| Q2 2019 | $169,000 | +668.2% | 69,769 | +772.1% | 0.00% | – |
| Q3 2018 | $22,000 | +2100.0% | 8,000 | +3100.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 250 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 250 | +150.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
| Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |